Stay updated on IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The site's footer revision identifier changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:30:32.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The site footer now identifies the release as v3.7.1 instead of v3.7.0. The page continues to show a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-10T14:20:47.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden error, preventing viewing the study details. This reflects a site access issue rather than a substantive update to the content.
    Difference
    19%
    Check dated 2026-09-19T18:36:57.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.5 to v3.6.6. This represents a minor version update that does not modify the displayed study details.
    Difference
    0.1%
    Check dated 2026-08-29T18:49:15.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page shows a new version label reflecting a release update from v3.6.4 to v3.6.5. This update does not modify the study details or visible content.
    Difference
    0.5%
    Check dated 2026-08-08T19:34:55.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    No additions or deletions were provided in the changes block. The page content remains unchanged in this context.
    Difference
    0.4%
    Check dated 2026-08-01T16:34:01.000Z thumbnail image

Stay in the know with updates to IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.